In a press release, Lilly announced that in its latest trial comparing its medication, Zepbound, to Wegovy, made by Novo ...
Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.
Health on MSN28m
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to ExpertsFact checked by Nick Blackmer GLP-1 medications like Ozempic and Wegovy have become popular for helping people lose weight or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback